Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| MODERNA | 35 | 84 | +1,43 % | ||
| GILEAD SCIENCES | 17 | 109 | -0,96 % | ||
| REGENERON PHARMACEUTICALS | 14 | 24 | -0,78 % | ||
| AMGEN | 6 | 30 | -1,03 % | ||
| ALEXION PHARMACEUTICALS | 6 | 8 | -1,42 % | ||
| SYNEOS HEALTH | 6 | 8 | -0,87 % | ||
| ALKERMES | 5 | 8 | +6,11 % | ||
| PACIRA BIOSCIENCES | 5 | 5 | -1,38 % | ||
| INCYTE | 4 | 5 | +1,29 % | ||
| LEXICON PHARMACEUTICALS | 4 | 4 | -9,34 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08:22 | Sanofi 2020 Q3 - Results - Earnings Call Presentation | - | Seeking Alpha | ||
| 08:05 | Aktien: Merck schraubt Gewinnziel nach oben - Moderna den Aktienkurs | Dennis Austinat | |||
| 07:44 | Gilead's COVID-19 drug is mediocre. It will be a blockbuster anyway. | 9 | Times of India | ||
| 07:34 | PTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz on Q3 2020 Results - Earnings Call Transcript | - | Seeking Alpha | ||
| 06:22 | Grifols Looks Enticing After Big Sell-Off In Spain | 3 | Seeking Alpha | ||
| 05:34 | Seagen's (SGEN) CEO Clay Siegall on Q3 2020 Results - Earnings Call Transcript | 5 | Seeking Alpha | ||
| 05:28 | Zusammengefasste Ergebnisse der Incyte-Studien TRuE-AD1 und TRuE-AD2 zur Behandlung von atopischer Dermatitis mit Ruxolitinib-Creme zeigen klinisch relevante Verbesserungen bei der patientenberichteten Lebensqualität | 163 | Business Wire | Den Daten zufolge führt die Behandlung mit Ruxolitinib-Creme zu einer raschen, substanziellen und nachhaltigen Verringerung des Juckreizes
Ergebnisse zeigen auch eine Verbesserung der von Patienten... ► Artikel lesen | |
| 04:34 | Insmed Incorporated (INSM) CEO Will Lewis on Q3 2020 Results - Earnings Call Transcript | 1 | Seeking Alpha | ||
| 03:58 | Illumina Inc. (ILMN) CEO Francis deSouza on Q3 2020 Results - Earnings Call Transcript | 10 | Seeking Alpha | ||
| 03:46 | Cerus Corporation (CERS) CEO Obi Greenman on Q3 2020 Results - Earnings Call Transcript | 4 | Seeking Alpha | ||
| 01:22 | VBI Vaccines: A Novice In COVID-19 Vaccine Race Outshines Moderna | 27 | Seeking Alpha | ||
| 01:10 | Sanofi (SNY) CEO Paul Hudson on Q3 2020 Results - Earnings Call Transcript | 4 | Seeking Alpha | ||
| Do | Why Moderna Stock Jumped Today | 15 | The Motley Fool | ||
| Do | Regeneron's Immunotherapy Is Given Priority Review for Treatment of New Lung Cancer Patients | 4 | The Motley Fool | ||
| Do | Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates | 294 | AFX News | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) revealed earnings for its third quarter that climbed from the same period last year.The company's profit came in at... ► Artikel lesen | |
| Do | EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q3 Earnings Report | 219 | AFX News | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Seattle Genetics Inc. (SGEN):-Earnings: $636.17 million in Q3 vs. -$91.91 million in the same period last year.
-EPS: $3.50 in... ► Artikel lesen | |
| Do | Moderna, Inc. (MRNA) CEO Stéphane Bancel on Q3 2020 Results - Earnings Call Transcript | 12 | Seeking Alpha | ||
| Do | Recap: Vertex Pharmaceuticals Q3 Earnings | 31 | Benzinga.com | ||
| Do | PTC THERAPEUTICS, INC. - 10-Q, Quaterly Report | - | SEC Filings | ||
| Do | Eidos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
